Impact of F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated Biomarkers.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published Date:

Abstract

We aimed to investigate the effects of F-FDG PET voxel intensity normalization on radiomic features of oropharyngeal squamous cell carcinoma (OPSCC) and machine learning-generated radiomic biomarkers. We extracted 1,037 F-FDG PET radiomic features quantifying the shape, intensity, and texture of 430 OPSCC primary tumors. The reproducibility of individual features across 3 intensity-normalized images (body-weight SUV, reference tissue activity ratio to lentiform nucleus of brain and cerebellum) and the raw PET data was assessed using an intraclass correlation coefficient (ICC). We investigated the effects of intensity normalization on the features' utility in predicting the human papillomavirus (HPV) status of OPSCCs in univariate logistic regression, receiver-operating-characteristic analysis, and extreme-gradient-boosting (XGBoost) machine-learning classifiers. Of 1,037 features, a high (ICC ≥ 0.90), medium (0.90 > ICC ≥ 0.75), and low (ICC < 0.75) degree of reproducibility across normalization methods was attained in 356 (34.3%), 608 (58.6%), and 73 (7%) features, respectively. In univariate analysis, features from the PET normalized to the lentiform nucleus had the strongest association with HPV status, with 865 of 1,037 (83.4%) significant features after multiple testing corrections and a median area under the receiver-operating-characteristic curve (AUC) of 0.65 (interquartile range, 0.62-0.68). Similar tendencies were observed in XGBoost models, with the lentiform nucleus-normalized model achieving the numerically highest average AUC of 0.72 (SD, 0.07) in the cross validation within the training cohort. The model generalized well to the validation cohorts, attaining an AUC of 0.73 (95% CI, 0.60-0.85) in independent validation and 0.76 (95% CI, 0.58-0.95) in external validation. The AUCs of the XGBoost models were not significantly different. Only one third of the features demonstrated a high degree of reproducibility across intensity-normalization techniques, making uniform normalization a prerequisite for interindividual comparability of radiomic markers. The choice of normalization technique may affect the radiomic features' predictive value with respect to HPV. Our results show trends that normalization to the lentiform nucleus may improve model performance, although more evidence is needed to draw a firm conclusion.

Authors

  • Stefan P Haider
    Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
  • Tal Zeevi
    Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
  • Kariem Sharaf
    Department of Otorhinolaryngology, LMU Clinic of Ludwig Maximilians University of Munich, Munich, Germany.
  • Moritz Gross
    Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA. moritz.gross@charite.de.
  • Amit Mahajan
    Department of Radiology, Yale School of Medicine, New Haven, CT.
  • Benjamin H Kann
    Artificial Intelligence in Medicine (AIM) Program, Harvard Medical School, Boston, Massachusetts, USA.
  • Benjamin L Judson
    Division of Otolaryngology, Yale School of Medicine, New Haven, Connecticut.
  • Manju L Prasad
    Department of Pathology, Yale School of Medicine, New Haven, Connecticut; and.
  • Barbara Burtness
    Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Mariam Aboian
    Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.
  • Martin Canis
    Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Christoph A Reichel
    Department of Otorhinolaryngology, LMU Clinic of Ludwig Maximilians University of Munich, Munich, Germany.
  • Philipp Baumeister
    Klinik für Urologie, Luzerner Kantonsspital, Luzern, Switzerland.
  • Seyedmehdi Payabvash
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.